FDA inspection
Bristol-Myers Squibb Company: FDA inspection ending Jul 2, 2003
FDA inspection 281085 · No Action Indicated (NAI) · Mount Vernon, IN
Key facts
| Inspection ID | 281085 |
|---|---|
| Firm | Bristol-Myers Squibb Company |
| FEI number | 1831144 |
| Address | 4401 Indiana Route 62 East, Building 101 |
| City | Mount Vernon |
| State | IN |
| ZIP | 47620 |
| Fiscal year | 2003 |
| Inspection end date | Jul 2, 2003 |
| Classification | No Action Indicated (NAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data